The CSS is part of the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute. The SEER program monitors cancer incidence and survival in approximately 34% of the US population. The CSS also provides data to the Washington State Cancer Registry, which monitors cancer incidence in the entire state of Washington.
The CSS is supported by funding from the SEER Program, with additional support from the Fred Hutch and the Washington State Department of Health.
Dr. Shivani Srivastava
CAR T-cell therapy researcher